Related Experiment Video
Updated: May 26, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
FABP5 confers resistance to drug-induced ROS toxicity in cervical cancer cell lines by suppressing the PPARγ/CPT1A
Ting Zhang1,2, Jiamei Zhu3, Li Geng4
1Department of Obstetrics and Gynecology, The First Afffliated Hospital of Soochow University, Suzhou, 215006, China.
Abstract:
Fatty acid-binding protein 5 (FABP5) is highly expressed in various tumor cell types and is associated with cancer progression. The aim of this study is to clarify the role of FABP5 in cervical cancer to determine its potential value as a clinical treatment target. Online bioinformatics platforms and immunohistochemistry (IHC) were used to analyze FABP5 expression and function in cervical squamous cell carcinoma (CESC). In vitro experiments revealed that overexpression of FABP5 significantly enhanced the proliferation, migration, and invasion abilities of cervical cancer cells. Moreover, resistance to the killing effects of cisplatin and paclitaxel was observed. RNA sequencing (RNA-seq) results and oil red cell (ORO) staining experiments revealed the key role of FABP5 in cellular metabolism. Protein‒protein interaction (PPI) network analysis revealed that by inhibiting the activation of the key lipid regulation signaling pathways PPARγ/CPT1A and ATP5A1, overexpression of FABP5 not only increased the energy reserves of cells but also reduced the level of reactive oxygen species (ROS) produced by fatty acid β-oxidation. Further experiments revealed that exogenous drugs could reduce the cellular energy reserve and activate PPARγ/CPT1A and ATP5A1. In conclusion, FABP5 increases cellular energy reserves while maintaining cells in a low-ROS state by inhibiting PPARγ/CPT1A signaling and downregulating the expression of the respiratory chain component ATP5A1. The PPARγ/CPT1A signaling pathway may represent one of the key mechanisms through which cells defend against exogenous ROS.
Insights
Fatty acid-binding protein 5 (FABP5) promotes cervical cancer progression by enhancing cell growth and chemoresistance. It achieves this by increasing cellular energy and reducing reactive oxygen species (ROS) via the PPARγ/CPT1A pathway.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Fatty acid-binding protein 5 (FABP5) is implicated in various cancers.
- Its specific role in cervical cancer progression and as a therapeutic target requires elucidation.
Purpose of the Study:
- To investigate the function of FABP5 in cervical squamous cell carcinoma (CESC).
- To assess FABP5 as a potential clinical treatment target for cervical cancer.
Main Methods:
- Bioinformatics analysis and immunohistochemistry (IHC) for FABP5 expression.
- In vitro cell culture, RNA sequencing (RNA-seq), oil red O (ORO) staining.
- Protein-protein interaction (PPI) network analysis.
Main Results:
- FABP5 overexpression enhanced CESC cell proliferation, migration, and invasion.
- FABP5 conferred resistance to cisplatin and paclitaxel chemotherapy.
- FABP5 regulates cellular metabolism, increasing energy reserves and reducing reactive oxygen species (ROS) by inhibiting PPARγ/CPT1A and ATP5A1 signaling.
Conclusions:
- FABP5 promotes cervical cancer progression and chemoresistance.
- FABP5 maintains cellular energy reserves and a low-ROS state by inhibiting the PPARγ/CPT1A pathway and downregulating ATP5A1.
- The PPARγ/CPT1A pathway is a key mechanism for cellular defense against ROS.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Treatment Resistant Cancers
Abnormal Proliferation

